Dr. Pierre Duquette, MD
Claim this profileStudies Multiple Sclerosis
1 reported clinical trial
1 drug studied
Clinical Trials Pierre Duquette, MD is currently running
More about Pierre Duquette, MD
Clinical Trial Related3 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical TrialTreatments Pierre Duquette, MD has experience with
- Cannabis Oil
Breakdown of trials Pierre Duquette, MD has run
Multiple Sclerosis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Pierre Duquette, MD specialize in?
Pierre Duquette, MD focuses on Multiple Sclerosis and other conditions. In particular, much of their work with Multiple Sclerosis has involved treating patients, or patients who are undergoing treatment.
Is Pierre Duquette, MD currently recruiting for clinical trials?
Yes, Pierre Duquette, MD is currently recruiting for 1 clinical trial in the USA. If you're interested in participating, you should apply.
Are there any treatments that Pierre Duquette, MD has studied deeply?
Yes, Pierre Duquette, MD has studied treatments such as Cannabis oil.
What is the best way to schedule an appointment with Pierre Duquette, MD?
Apply for one of the trials that Pierre Duquette, MD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.